tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Enveric Biosciences receives notice of allowance from USPTO

Enveric Biosciences (ENVB) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering compositions of matter and methods of use for a novel class of aminated tryptamine derivatives. The patented compounds were designed through Enveric’s proprietary discovery platform and represent an approach to non-hallucinogenic psychedelic-inspired therapeutics. The compounds demonstrated low hallucinogenic liability in preclinical testing, including minimal Head Twitch Response and reduced 5-HT2A receptor activation – two established indicators of hallucinogenic activity in rodents.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1